Advertisement
UK markets close in 8 hours

  • FTSE 100

    7,886.02
    +38.03 (+0.48%)
     

  • FTSE 250

    19,368.95
    +28.81 (+0.15%)
     

  • AIM

    743.34
    +0.22 (+0.03%)
     

  • GBP/EUR

    1.1669
    +0.0002 (+0.01%)
     

  • GBP/USD

    1.2467
    +0.0011 (+0.09%)
     

  • Bitcoin GBP

    49,133.38
    -1,892.38 (-3.71%)
     

  • CMC Crypto 200

    885.54
    0.00 (0.00%)
     

  • S&P 500

    5,022.21
    -29.20 (-0.58%)
     

  • DOW

    37,753.31
    -45.66 (-0.12%)
     

  • CRUDE OIL

    82.69
    0.00 (0.00%)
     

  • GOLD FUTURES

    2,394.20
    +5.80 (+0.24%)
     

  • NIKKEI 225

    38,079.70
    +117.90 (+0.31%)
     

  • HANG SENG

    16,413.16
    +161.32 (+0.99%)
     

  • DAX

    17,822.32
    +52.30 (+0.29%)
     

  • CAC 40

    8,022.35
    +40.84 (+0.51%)
     
Money:

5 ways to get help with childcare costs

Childcare is eye-wateringly expensive, here are some ways to save money

BAT nicotine inhaler licensed as medicinal product in UK

Reuters - UK Focus

LONDON, Sept 12 (Reuters) - A new nicotine inhaler to be sold by a unit of British American Tobacco (LSE: BATS.L - news) has been licensed in the UK as a medicinal product, marking the arrival of a new competitor in the fast-growing electronic cigarette market.

The Voke Inhaler contains no electronics, heat or combustion and is designed to rival both e-cigarettes and nicotine-replacement therapies, such as gum and patches.

The product was developed by Kind Consumer, working with Consort Medical (Other OTC: CSRMY - news) , and the next step will be to submit a variation to the licence granted by the Medicines and Healthcare products Regulatory Agency (MHRA) to support full-scale commercialisation by BAT's Nicoventures, the companies said.

(Reporting by Ben Hirschler, Editing by Paul Sandle)